Cambridge, United Kingdom

Kate Wittering

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Kate Wittering

Introduction

Kate Wittering is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of new treatments for various diseases. With a total of 2 patents, her work is recognized for its potential impact on public health.

Latest Patents

Wittering's latest patents focus on salts and polymorphs of cethromycin for the treatment of diseases caused by bacterial infections and certain protozoans. These include serious conditions such as malaria, Babesiosis, Toxoplasmosis, and various respiratory diseases. Additionally, her patents address inflammatory diseases, including pelvic inflammatory disease and peptic ulcer disease. The innovative formulations she has developed aim to combat both infectious and inflammatory conditions effectively.

Career Highlights

Kate Wittering is currently associated with AliquantumRx, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving therapeutic options for patients suffering from complex diseases.

Collaborations

Wittering collaborates with Amanda Hill, a fellow innovator in the field. Together, they work on projects that aim to enhance the efficacy of treatments and expand the scope of available medical solutions.

Conclusion

Kate Wittering's contributions to the field of medicine through her innovative patents highlight her dedication to improving health outcomes. Her work exemplifies the vital role of inventors in advancing medical science and addressing pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…